Literature DB >> 25579115

Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome.

Chrystal Chan1,2, Gregory Costain1,2, Lucas Ogura1, Candice K Silversides3,4,5, Eva W C Chow1,6, Anne S Bassett7,8,9,10,11,12.   

Abstract

22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion syndrome in humans. Survival to reproductive age and beyond is now the norm. Several manifestations of this syndrome, such as congenital cardiac disease and neuropsychiatric disorders, may increase risk for adverse pregnancy outcomes in the general population. However, there are limited data on reproductive health in 22q11.2DS. We performed a retrospective chart review for 158 adults with 22q11.2DS (75 male, 83 female; mean age 34.3 years) and extracted key variables relevant to pregnancy and reproductive health. We present four illustrative cases as brief vignettes. There were 25 adults (21 > age 35 years; 21 female) with a history of one or more pregnancies. Outcomes for women with 22q11.2DS, compared with expectations for the general population, showed a significantly elevated prevalence of small for gestational age liveborn offspring (p < 0.001), associated mainly with infants with 22q11.2DS. Stillbirths also showed elevated prevalence (p < 0.05). Not all observed adverse events appeared to be attributable to transmission of the 22q11.2 deletion. Recurring issues relevant to reproductive health in 22q11.2DS included the potential impact of maternal morbidities, inadequate social support, unsafe sexual practices, and delayed diagnosis of 22q11.2DS and/or lack of genetic counseling. These preliminary results emphasize the importance of early diagnosis and long term follow-up that could help facilitate genetic counseling for men and women with 22q11.2DS. We propose initial recommendations for pre-conception management, educational strategies, prenatal planning, and preparation for possible high-risk pregnancy and/or delivery.

Entities:  

Keywords:  Contraception; DiGeorge syndrome; Genomic disorder; Pregnancy complications; Prenatal testing; Velocardiofacial syndrome

Mesh:

Year:  2015        PMID: 25579115      PMCID: PMC4567324          DOI: 10.1007/s10897-014-9811-7

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  54 in total

Review 1.  Pregnancy in heart disease.

Authors:  S A Thorne
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

2.  Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Rebecca McEvilly; Jessica Fong; Candice Silversides; Eva Chow; Anne Bassett
Journal:  Am J Psychiatry       Date:  2010-08       Impact factor: 18.112

3.  The sexual safety of adolescents.

Authors:  Heidi Collins Fantasia; Holly B Fontenot
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2011-02-01

4.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

5.  Chromosome 22q11 deletion presenting as the Potter sequence.

Authors:  K Devriendt; P Moerman; D Van Schoubroeck; K Vandenberghe; J P Fryns
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

Review 6.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

7.  Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders.

Authors:  Assen V Jablensky; Vera Morgan; Stephen R Zubrick; Carol Bower; Li-Anne Yellachich
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

8.  The 2002 Canadian Contraception Study: Part 2.

Authors:  William Fisher; Richard Boroditsky; Brian Morris
Journal:  J Obstet Gynaecol Can       Date:  2004-07

9.  A population study of chromosome 22q11 deletions in infancy.

Authors:  J Goodship; I Cross; J LiLing; C Wren
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

10.  22q11 deletion: a multisystem disorder requiring multidisciplinary input.

Authors:  K L Greenhalgh; I A Aligianis; G Bromilow; H Cox; C Hill; Y Stait; B J Leech; P W Lunt; M Ellis
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

View more
  5 in total

Review 1.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

2.  Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.

Authors:  Anne S Bassett; Gregory Costain; Christian R Marshall
Journal:  Prenat Diagn       Date:  2016-11-14       Impact factor: 3.050

Review 3.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

4.  The psychosocial impact of 22q11 deletion syndrome on patients and families: A systematic review.

Authors:  Oanh Kieu Vo; Alisdair McNeill; Katharina Sophie Vogt
Journal:  Am J Med Genet A       Date:  2018-03-25       Impact factor: 2.802

Review 5.  Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels.

Authors:  Małgorzata Karbarz
Journal:  Genes (Basel)       Date:  2020-08-22       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.